RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CANEVARI RF
Collezione AO Ordine Mauriziano

Items : 4

Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab. in Journal of personalized medicine / J Pers Med. 2025 Jan 23;15(2):43. doi: 10.3390/jpm15020043.

2025
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Fedele S; Bertolini M; Canevari RF; Caruso C; Senna G; Caminati M; Pini L; Spanevello A; Visca D; Gollinucci C; Guida G; Tiotiu A; Cameli P; Nicola S; Brussino L; Bondi B; Bagnasco D; Mincarini M; Canonica GW; Braido F; On Behalf Of The Sani Group;

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders. in Biomedicines / Biomedicines. 2023 Aug 30;11(9):2424. doi: 10.3390/biomedicines11092424.

2023
AO Ordine Mauriziano

Bagnasco D; Nicola S; Testino E; Brussino L; Pini L; Caminati M; Piccardo F; Canevari RF; Melissari L; Ioppi A; Guastini L; Lombardi C; Milanese M; Losa F; Robbiano M; De Ferrari L; Riccio AM; Guida G; Bonavia M; Fini D; Balbi F; Caruso C; Paggiaro P; Blasi F; Heffler E; Paoletti G; Canonica GW; Senna G; Passalacqua G; et alii...

Specific Therapy for T2 Asthma. in Journal of personalized medicine / J Pers Med. 2022 Apr 7;12(4):593. doi: 10.3390/jpm12040593.

2022
AO Ordine Mauriziano

Bagnasco D; Testino E; Nicola S; Melissari L; Russo M; Canevari RF; Brussino L; Passalacqua G;

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life. in The World Allergy Organization journal / World Allergy Organ J. 2021 Jan 27;14(2):100509. doi: 10.1016/j.waojou.2021.100509. eCollection 2021

2021
AO Ordine Mauriziano
AOU Città della Salute di Torino

Canevari RF; Bucca C; Manfredi A; Lombardi C; Milanese M; Senna G; Paggiaro P; Canonica GW; Menzella F; Heffler E; Rolla G; Caminati M; Povero M; Pradelli L; Brussino L; Bagnasco D; Passalacqua G;